Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

E2F4 deficiency promotes drug-induced apoptosis.

Yihong Ma1, Scott N Freeman, W Douglas Cress

  • 1Molecular Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida College of Medicine, Tampa, Florida 33612-9497, USA.

Cancer Biology & Therapy
|December 22, 2004
PubMed
Summary

The study reveals that E2F4 promotes resistance to apoptosis, while E2F1 enhances cell death. Manipulating these transcription factors impacts sensitivity to chemotherapy and kinase inhibitors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electroacupuncture for essential hypertension: Mechanistic insights, current clinical evidence, and translational challenges.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
Same author

Molecular Detection and Identification of Bacterial Pathogens in Qinghai Province, China.

Pathogens (Basel, Switzerland)·2026
Same author

Ribonucleotide reductase M1 regulates the cell cycle via minichromosome maintenance proteins.

Genes & diseases·2026
Same author

A Survey of Spotted Fever Group Rickettsia and Anaplasmataceae Bacteria in Questing Ticks in Hokkaido, Japan.

Vector borne and zoonotic diseases (Larchmont, N.Y.)·2026
Same author

A H2O2-self-supplying and oxygen-evolving nanosystem for amplified chemodynamic therapy of breast cancer.

Colloids and surfaces. B, Biointerfaces·2025
Same author

An epidemiological survey of zoonotic Babesia species in questing ticks in Hokkaido, Japan, using a newly developed PCR-sequencing approach.

Parasitology international·2025

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • E2F1 and E2F4 are transcription factors known to have opposing roles in cell cycle regulation.
  • Understanding their roles in apoptosis is crucial for developing effective cancer therapies.

Purpose of the Study:

  • To investigate the roles of E2F1 and E2F4 in apoptosis induced by cyclin-dependent kinase inhibitors and chemotherapeutic drugs.
  • To determine how the expression levels of E2F1 and E2F4 are affected by these treatments.
  • To assess the impact of E2F4 and E2F1 deficiency on drug-induced apoptosis.

Main Methods:

  • Treatment of mouse fibroblasts and human cancer cells with cyclin-dependent kinase inhibitors (roscovitine, BMS-387032, flavopiridol) and chemotherapeutic drugs (VP16, cisplatin, paclitaxel).

Related Experiment Videos

  • Analysis of E2F1 and E2F4 protein levels following drug treatment.
  • Assessment of apoptosis in E2F4-null and E2F1-deficient mouse fibroblasts.
  • Evaluation of drug sensitivity in human cancer cells with RNAi-mediated reduction of E2F4.

    • Main Results:

    • Cyclin-dependent kinase inhibitors and DNA-damaging drugs decreased E2F4 levels and increased E2F1 levels.
    • E2F4-deficient fibroblasts showed increased sensitivity to apoptosis induced by the tested drugs.
    • E2F1-deficient fibroblasts exhibited decreased sensitivity to drug-induced apoptosis.
    • Reduced E2F4 levels in human cancer cells via RNAi led to increased sensitivity to these drugs.

    Conclusions:

    • E2F1 and E2F4 play opposing roles in drug-induced apoptosis.
    • E2F4 acts as a suppressor of apoptosis, while E2F1 promotes it.
    • Targeting E2F4 or E2F1 could be a therapeutic strategy to enhance cancer treatment efficacy.